ℹ️
🇬🇧
Search
Search for people relevant for "linie"
linie
Person
Class
Person
Publication
Programmes
Export current view
MUDr. Michal Hrnčiarik
Academic staff at Faculty of Medicine in Pilsen
47 publications
Publications
publication
Effect of clinical parameters on second- and third-line erlotinib treatment of EGFR wild type patients with advanced NSCLC
2019 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
publication
Treatment of malignant pleural mesothelioma in the Czech Republic
2019 |
Faculty of Medicine in Pilsen, Central Library of Charles University
publication
Effects of Treatment with Crizotinib on Non-small Cell Lung Carcinoma with ALK Translocation in the Czech Republic
2018 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Monitoring of the expensive pneumooncological first-line treatment of the advanced non-small cell lung cancer in the TULUNG register in the Czech Republic
2017 |
Faculty of Medicine in Pilsen, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Follow-up of expensive pneumo-oncological treatment of advanced non-small cell lung cancer in the I. line of the TULUNG register in the Czech Republic
2013 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University
publication
New options of expensive pneumo-oncological therapy for advanced non-small-cell lung carcinoma (NSCLC) in the first line based on morphological and molecular genetic diagnosis in the Czech Republic
2012 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University
publication
Monitoring of the expensive pneumooncological tratment of the advanced non-small cell lung cancer (NSCLC) in the 1st line in the TULUNG registry in the Czech Republic
2012 |
Third Faculty of Medicine, First Faculty of Medicine
publication
Efficiency and safety of pemetrexed and cisplatin therapy in the adenocarcinoma and large cell cancer types of advanced non-small cell lung cancer (NSCLC)
2012 |
Publication without faculty affiliation
publication
Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer
2023 |
Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
publication
Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer
2023 |
Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
Load more publications (37)
Loading network view...